You are here

BARDA

Cue Health wins $28M BARDA contract to develop rapid respiratory infection test

Cue Health wins $28M BARDA contract to develop rapid respiratory infection test

Medtech Dive

Flag link:

Bavarian Nordic locks up $120M BARDA deal to replenish US stock of smallpox, mpox vaccine

Bavarian Nordic locks up $120M BARDA deal to replenish US stock of smallpox, mpox vaccine

Fierce Pharma

Bavarian Nordic

Flag link:

Expanding its pandemic influenza preparedness, Sanofi breaks ground on state-of-the-art facility in Pennsylvania

Expanding its pandemic influenza preparedness, Sanofi breaks ground on state-of-the-art facility in Pennsylvania

ROI-NJ

drug manufacturing

Flag link:

Budget law calls for BARDA and FDA to establish “warm base” manufacturing to better prepare for future pandemics

Budget law calls for BARDA and FDA to establish “warm base” manufacturing to better prepare for future pandemics

RAPS.org

drug manufacturing

Flag link:

In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb

In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb

Endpoints

Vir Biotechnology

federal contracts

Flag link:

Bavarian Nordic to supply additional monkeypox vaccine doses to US

Bavarian Nordic to supply additional monkeypox vaccine doses to US

Pharmaceutical Business Review

Bavarian Nordic

Flag link:

Bavarian Nordic expands monkeypox vaccine deal with US and updates '22 sales figures — again

Bavarian Nordic expands monkeypox vaccine deal with US and updates '22 sales figures — again

Endpoints

Bavarian Nordic

Flag link:

As monkeypox quickly spreads, a handful of biotechs spring to action

As monkeypox quickly spreads, a handful of biotechs spring to action

Endpoints

Emergent BioSolutions

Bavarian Nordic

Flag link:

Doctor groups urge Biden administration to disclose costs of federally funded clinical trials

Doctor groups urge Biden administration to disclose costs of federally funded clinical trials

Fierce Biotech

clinical trials

Flag link:

Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment

Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment

Endpoints

Vedanta Biosciences

clinical trials

Flag link:

BARDA slows its $9B engine for new Covid-19 therapeutics

BARDA slows its $9B engine for new Covid-19 therapeutics

Endpoints

Flag link:

COVID-19: Meissner secures $13.4m BARDA award to produce single-use systems

COVID-19: Meissner secures $13.4m BARDA award to produce single-use systems

Biopharma Reporter

Meissner Filtration

drug manufacturing

Flag link:

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

Endpoints

clinical trials

Flag link:

Beckman Coulter Receives Grant to Detect Serious COVID-19 Complication in Kids

Beckman Coulter Receives Grant to Detect Serious COVID-19 Complication in Kids

BioSpace

Beckman Coulter

Flag link:

Cytiva tasked with COVID-19 vaccine work as part of $31M U.S. government grant

Cytiva tasked with COVID-19 vaccine work as part of $31M U.S. government grant

Fierce Pharma

General Electric

government funding

Flag link:

BARDA and Locus in tie-up to tackle UTIs with phages

BARDA and Locus in tie-up to tackle UTIs with phages

Biopharma Reporter

Locus Biosciences

Flag link:

AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail

AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail

Motley Fool

Flag link:

BARDA chief turned whistleblower Rick Bright resigns from government with one last broadside against the Trump administration

BARDA chief turned whistleblower Rick Bright resigns from government with one last broadside against the Trump administration

Endpoints

Flag link:

HHS gives Vaxxas $22M to support vaccine patch tech

HHS gives Vaxxas $22M to support vaccine patch tech

Mass Device

clinical trials

vaccine patches

Flag link:

PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy

PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy

Pharmaforum

Vedanta Biosciences

Flag link:

Pages